Nephrogenic Systemic Fibrosis: Histology and Gadolinium Detection

被引:16
|
作者
Thakral, Charu [1 ]
Abraham, Jerrold L. [1 ]
机构
[1] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA
关键词
Nephrogenic systemic fibrosis; Histopathology; Gadolinium; Scanning electron microscopy; Energy dispersive x-ray spectroscopy; Mass spectrometry; Tissue analysis; Secondary ion mass spectrometry; LONG-TERM RETENTION; STAGE RENAL-DISEASE; CONTRAST AGENTS; DERMOPATHY; TISSUE; SKIN; QUANTIFICATION; INVOLVEMENT; MICROSCOPY; DEPOSITION;
D O I
10.1016/j.rcl.2009.06.005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The association between gadolinium (Gd)-containing MR imaging contrast agents and the development of nephrogenic systemic fibrosis (INISF) is well recognized. The authors review the histopathologic features, methodology, and results Of analysis of tissues for Gd in NSF. Scanning electron microscopy/energy dispersive xray spectroscopy (SEM/EDS) provides sensitive detection of individual Gd-containing deposits in situ. Secondary ion mass spectroscopy has far greater sensitivity for detection of Gd than SEM/EDS and allows correlation at the cellular level. Inductively coupled plasma mass spectrometry is the recognized method for full quantitative analysis of Gd in tissues but requires destruction of the tissue and does not allow spatial correlation. In practice, the different analytic techniques provide complementary data and can be selected based on the information required.
引用
收藏
页码:841 / +
页数:15
相关论文
共 50 条
  • [31] Gadolinium and nephrogenic systemic fibrosis: time to tighten practice
    Iosif A. Mendichovszky
    Stephen D. Marks
    Clare M. Simcock
    Øystein E. Olsen
    Pediatric Radiology, 2008, 38 : 489 - 496
  • [32] Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis
    Abraham, Jerrold L.
    Thakral, Charu
    EUROPEAN JOURNAL OF RADIOLOGY, 2008, 66 (02) : 200 - 207
  • [33] Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents
    Jeffrey G. Penfield
    Pediatric Nephrology, 2008, 23 : 2121 - 2129
  • [34] Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents
    Penfield, Jeffrey G.
    PEDIATRIC NEPHROLOGY, 2008, 23 (12) : 2121 - 2129
  • [35] The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update
    Idee, Jean-Marc
    Fretellier, Nathalie
    Robic, Caroline
    Corot, Claire
    CRITICAL REVIEWS IN TOXICOLOGY, 2014, 44 (10) : 895 - 913
  • [36] Nephrogenic Systemic Fibrosis: Clinical Picture and Treatment
    Marckmann, Peter
    Skov, Lone
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2009, 47 (05) : 833 - +
  • [37] Renal function, nephrogenic systemic fibrosis and other adverse reactions associated with gadolinium-based contrast media
    Canga, Ana
    Kislikova, Maria
    Martinez-Galvez, Maria
    Arias, Mercedes
    Fraga-Rivas, Patricia
    Poyatos, Cecilio
    de Francisco, Angel L. M.
    NEFROLOGIA, 2014, 34 (04): : 428 - 438
  • [38] Nephrogenic Systemic Fibrosis A Concise Review for Cardiologists
    Cheong, Benjamin Y. C.
    Muthupillai, Raja
    TEXAS HEART INSTITUTE JOURNAL, 2010, 37 (05) : 508 - 515
  • [39] Nephrogenic Systemic Fibrosis: Clinical Spectrum of Disease
    Mayr, Michael
    Burkhalter, Felix
    Bongartz, Georg
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 30 (06) : 1289 - 1297
  • [40] Dermal inorganic gadolinium concentrations:: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis
    Abraham, J. L.
    Thakral, C.
    Skov, L.
    Rossen, K.
    Marckmann, P.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (02) : 273 - 280